Session » Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Treatment II: Pathogenesis, Exercise, and Dietary Interventions (2687–2692)
- 11:30AM-11:45AM
-
Abstract Number: 2687
Glucagon-like peptide-1 receptor agonists therapy is associated in improvement in psoriatic arthritis-related and metabolic outcomes: A retrospective analysis of two cohorts
- 11:45AM-12:00PM
-
Abstract Number: 2688
Single cell RNA-seq immune profiling of blood samples from a psoriatic disease clinical trial reveals a CD4 T cell population associated with response to IL-23 blockade
- 12:00PM-12:15PM
-
Abstract Number: 2689
Comparison of Incidence of Psoriatic Arthritis in Patients With Psoriasis Treated With Interleukin-17 Inhibitors vs Interleukin-23 Inhibitors, Interleukin-12/23 Inhibitors, and Tumor Necrosis Factor Inhibitors in Real-World Practice: A Retrospective Study
- 12:15PM-12:30PM
-
Abstract Number: 2690
Dietary interventions in Psoriatic Arthritis: A Randomized controlled clinical trial
- 12:30PM-12:45PM
-
Abstract Number: 2691
Understanding the Impact of Overweight and Obesity on Treatment Response in Psoriatic Arthritis: Results from a Longitudinal Cohort Study
- 12:45PM-1:00PM
-
Abstract Number: 2692
Individualized Strength, Mobility and Aerobic Rehabilitation Training in axial Spondyloarthritis (iSMART in axSpA)